Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc.

 
DOCKET NO.
OP. BELOW
SUBJECT
Patent

Question(s) Presented

1. “Whether, in a pending case, a court can refuse to entertain a constitutional, separation-of-powers challenge based on an intervening change of law on the grounds of forfeiture.” 2. “Whether the Federal Circuit’s obviousness holding is an unwarranted expansion of this Court’s decision in KSR International Co. v. Teleflex, Inc., 550 U.S. 398 (2007), and is inconsistent with the Patent Act.”

Posts About this Case

Date
Proceedings and Orders
July 29, 2020
Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.